Tuesday, December 30, 2025
ADVT 
International

U.S. House passes plan to decriminalize marijuana

Darpan News Desk The Canadian Press, 01 Apr, 2022 10:39 AM
  • U.S. House passes plan to decriminalize marijuana

WASHINGTON - It may be April Fools' Day, but Democrats in Congress are nonetheless getting serious about legalizing marijuana in the United States.

By a margin of 220-204, members of the House of Representatives have voted in favour of legislation that would decriminalize the drug at the federal level.

Two Democrats voted against the Marijuana Opportunity Reinvestment and Expungement Act, while two Republicans voted in favour.

The bill, better known as the MORE Act, would also eliminate pot-related criminal penalties, impose new excise taxes and fast-track expunging marijuana convictions.

The bill now moves to the Senate, where it is expected to face a more difficult climb.

Not only is the Senate evenly split between Republicans and Democrats, but Majority Leader Chuck Schumer has plans for a similar bill to be introduced later this month.

MORE International ARTICLES

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate